A Defined Region of Loss of Heterozygosity at 11q23 in Cutaneous Malignant Melanoma

Cancer Research

Volumn 55, Issue 12, 1995, Pages 2494-2496

  Herbst, Rudolf A ^a,b   Larson, Amy ^a   Weiss, Jürgen ^b   Cavenee, Webster K ^a   Hampton, Garret M ^a   Arden, Karen C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; AUTORADIOGRAPHY; CANCER STAGING; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MELANOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA; DNA, NEOPLASM; GENETIC MARKERS; HUMAN; LYMPHOCYTES; MELANOMA; MIDDLE AGE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0029002574     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Herlyn, M. Etiology of melanoma. In: M. Herlyn (ed.), Molecular and Cellular Biology of Melanoma, pp. 5–20. Austin, TX: Landes Co., 1993.
2. Fountain, J. W., Bale, S. J., Housman, D. E., and Dracopoli, N. C. Genetics of melanoma. Cancer Surv., 9: 645–671, 1990.
3. Walker, G. J., Palmer, J. M., Walters, M. K., and Hayward, N. K. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer, 12: 134–141, 1995.
4. Kamb, A., Shattuck, E. D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver, F. J., et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 23–26, 1994.
5. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. J., Tucker, M. A., and Dracopoli, N. C. Germline pl6 mutations in familial melanoma. Nat. Genet., 8: 15–21, 1994.
6. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22–10qter in malignant melanoma progression. Cancer Res., 54: 3111–3114, 1994.
7. Keldysh, P. L., Dragani, T. A., Fleischman, E. W., Konstantinova, L. N., Perevos-chikov, A. G., Pierotti, M. A., Delia, P. G., and Kopnin, B. P. 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer, 6: 45–50, 1993.
8. Foulkes, W. D., Campbell, I. G., Stamp, G. W., and Trowsdale, J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br. J. Cancer, 67: 268–273, 1993.
9. Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewer, C., Liao, S., Busby, E. R., Williams, A. W., Steel, C. M., Bird, C. C., et al Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc. Natl. Acad. Sci. USA, 91: 6953–6957,1994.
10. Carter, S. L., Negrini, M., Baffa, R., Gillum, D. R., Rosenberg, A. L., Schwartz, G. F., and Croce, C. M. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res., 54: 6270–6274, 1994.
11. Hampton, G. M., Mannermaa, A., Winquist, R., Alavaikko, M., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I., Cavenee, W. K., and Evans, G. A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 1 lq22 and llq23.3. Cancer Res., 54: 4586–4589, 1994.
12. Morse, H. G., Gonzalez, R., Moore, G. E., and Robinson, W. A. Preferential chromosome llq and/or 17q aberrations in short-term cultures of metastatic melanoma in resections from human brain. Cancer Genet. Cytogenet., 64:118–126,1992.
13. Nedoszytko, B., Mrozek, K., and Limon, J. Absence of structural rearrangements of chromosome 11 in human primary malignant melanoma. Cancer Genet. Cytogenet., 58: 196–197, 1992.
14. Trent, J. M., Meyskens, F. L., Salmon, S. E., Ryschon, K., Leong, S. P., Davis, J. R., and McGee, D. L. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N. Engl. J. Med., 322: 1508–1511, 1990.
15. Tomlinson, I. P., Gammack, A. J., Stickland, J. E., Mann, G. J., MacKie, R. M., Kefford, R. F., and McGee, J. O. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers. Genes Chromosomes Cancer, 7: 169–172, 1993.
16. Healy, E., Rehman, I., Angus, B., and Rees, J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer, 12: 152–156, 1995.
17. Iwasaki, H., Stewart, P. W., Dilley, W. G., Holt, M. S., Steinbrueck, T. D., Wells, S. J., and Donis-Keller, H. A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen Phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95. Genomics, 13: 7–15,1992.
18. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., and Lathrop, M. A second-generation linkage map of the human genome. Nature (Lond.), 359: 794–801, 1992.
19. Litt, M., Sharma, V., and Luty, J. A. Dinucleotide repeat polymorphism at the DUS35 locus. Nucleic Acids Res., 18: 5921, 1990.
20. Bhattacharya, S., Wilson, T. M., Wojciechowski, A. P., Volpe, C. P., and Scott, J. Hypervariable polymorphism in the APOC3 gene. Nucleic Acids Res., 19: 4799, 1991.
21. Centre d'Etude du Polymorphisme Humain. CEPH Average Map. Baltimore: The Johns Hopkins University School of Medicine, 1995.
22. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172: 902–908, 1970.
23. Ketcham, A. S., Moffat, F. L., and Balch, C. M. Classification and staging. In: C. M. Balch, A. N. Houghton, G. W. Milton, A. J. Sober, and S-j. Soong (eds.), Cutaneous Melanoma, pp. 216–217. Philadelphia, PA: J. B. Lippincott Co., 1992.
24. Negrini, M., Sabbioni, S., Possati, L., Rattan, S., Corallini, A., Barbanti, B. G., and Croce, C. M. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res., 54: 1331–1336, 1994.
25. Coleman, A., Robertson, G., Mote, P., and Lugo, T. G. Chromosome 11 suppresses cell growth and tumorigenicity in human malignant melanoma cells (Abstract). Proc. Am. Assoc. Cancer Res., 36: 196, 1995.